(Q38109751)

29 August 2017

title

Individualized glycaemic targets and pharmacotherapy in type 2 diabetes (English)

1 reference

29 August 2017

0 references

0 references

Clifford J Bailey

1

1 reference

29 August 2017

Pablo Aschner

2

1 reference

29 August 2017

Stefano Del Prato

3

1 reference

29 August 2017

James LaSalle

4

1 reference

29 August 2017

Linong Ji

5

1 reference

29 August 2017

Stephan Matthaei

6

1 reference

29 August 2017

Global Partnership for Effective Diabetes Management

7

1 reference

29 August 2017

language of work or name

English

0 references

publication date

27 May 2013

1 reference

Diabetes and Vascular Disease Research

29 August 2017

published in

1 reference

29 August 2017

volume

10

1 reference

29 August 2017

issue

5

1 reference

29 August 2017

page(s)

397-409

1 reference

Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Multidrug treatment of type 2 diabetes: a challenge for compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Standards of medical care in diabetes--2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Metabolic memory for vascular disease in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Treatment of type 2 diabetes in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

A clinical trial to maintain glycemic control in youth with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Patient adherence to medication requirements for therapy of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

A randomized trial of therapies for type 2 diabetes and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Megatrials in type 2 diabetes. From excitement to frustration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Hypoglycemia and cardiovascular risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Serious cardiovascular outcomes in diabetes: the role of hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Periconceptional care of women with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Does pregnancy accelerate the rate of progression of diabetic retinopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Metformin versus insulin for the treatment of gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

Renal glucose reabsorption inhibitors to treat diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490765

21 January 2018

Identifiers

DOI

10.1177/1479164113490765

1 reference

29 August 2017

1 reference